The total cost of raising a child with Angelman syndrome (AS) is almost $100,000 AUD — more than $70,000…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Researchers have reported the case of a teenager with Angelman syndrome (AS) in Brazil who developed severe COVID-19 but…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
A newly funded research project seeks to create cellular models that can be used to study two of the less…
Children with Angelman syndrome respond to different types of rewards to promote learning, and the preferred type may vary based…
In-person social engagement is more important for fostering imitative behaviors in children with Angelman syndrome than in typically-developing children, a…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
Neuren Pharmaceuticals has begun manufacturing of NNZ-2591, an investigational treatment for Angelman syndrome and other diseases, for use in…
Ovid Therapeutics‘ OV101 (gaboxadol) has been granted a rare…